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ABSTRACT
Guanine-rich DNA and RNA sequences can fold into
higher-order structures known as G-quadruplexes
(or G4-DNA and G4-RNA, respectively). The preva-
lence of the G4 landscapes in the human genome,
transcriptome and ncRNAome (non-coding RNA),
collectively known as G4ome, is strongly suggestive
of biological relevance at multiple levels (gene ex-
pression, replication). Small-molecules can be used
to track G4s in living cells for the functional char-
acterization of G4s in both normal and disease-
associated changes in cell biology. Here, we describe
biotinylated biomimetic ligands referred to as Bio-
TASQ and their use as molecular tools that allow
for isolating G4s through affinity pull-down proto-
cols. We demonstrate the general applicability of the
method by purifying biologically relevant G4s from
nucleic acid mixtures in vitro and from human cells
through the G4RP-RT-qPCR protocol. Overall, the re-
sults presented here represent a step towards the
optimization of G4-RNAs identification, a key step in
studying G4s in cell biology and human diseases.
INTRODUCTION
Guanine-rich (G-rich) DNA and RNA sequences have re-
cently earned a solid reputation as key genetic regulators,
owing to their capacity to fold into higher-order, four-
stranded structures known as G-quadruplexes (or G4). (1).
Recent advances in massively parallel sequencing (2) have
helped gain insights into both the prevalence and func-
tional relevance ofG4s in the human genome and transcrip-
tome. Quadruplex-specific small-molecules (or G4-ligands)
(3) were pivotal for these next-generation sequencing (NGS)
investigations, allowing for promoting and/or stabilizing
quadruplex structures, therefore making them detectable
during the NGS analyses. Pyridostatin (PDS) has been
particularly instrumental: (4) PDS was used in G4-seq to
cause polymerase stalling at ligand-stabilizedDNAG4 sites
which leads to altered nucleobase calling used as a con-
venient NGS readout (the Phred quality score). (5) This
allowed for the identification of over 716 000 potentially
DNA quadruplex-forming sequences (QFS) in the human
genome. Using G4 ChIP-seq, 10 000 G4 sites were detected,
a reduction in number of detected G4s from previous esti-
mate, likely due to the intrinsic topological constraints of
the chromatin environment. (6,7) PDSwas also used in rG4-
seq since PDS-stabilized RNA G4s likewise trigger reverse
transcriptase stalling (RTS), leading to the report of a RNA
G4 landscape comprising 13 400 QFS (in polyA-enriched
RNA, corresponding to 5 800 genes) in the human tran-
scriptome. (8) Chemically modified PDS derivatives were
useful as well, allowing for the first isolation of quadru-
plexes from purified human DNA (biotinylated PDS) (9)
and the first visualization of G4s in human cells (alkyny-
lated PDS, known as PDS-). (10) It is thus indisputable
that selective and chemically versatile ligands are invaluable
chemical biology tools for providing a deeper understand-
ing of the complex cell biology of DNA/RNA quadru-
plexes.
Over the past years, template-assembled synthetic G-
quartet (TASQ)-based G4 ligands have proven successful
in targeting quadruplexes via an actively selective, bioin-
spired ligand/target association: (11) for instance, twice-
as-smart ligands such as PyroTASQ allowed for visualiz-
ing G4s in vitro (12) while NaphthoTASQ (or N-TASQ) al-
lowed for tracking both DNA and RNA G4s in fixed cells
(13) and RNA G4s in living cells. (14) More recently, we
reported on a biotinylated TASQ named BioTASQ (here
referred to as BioTASQ v.1) that was used for developing
the G4RP-seq protocol (G4-RNA–specific precipitation-
sequencing). (15) As further discussed below, G4RP-seq is
a NGS technique that can be used for studying RNA G4-
landscapes transcriptome-wide, evaluating the quantitative
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changes upon G4-ligand treatment and uniquely highlight-
ing a strong correlation between high G4RP signals and the
number of G4s in RNA, notably long non-coding RNA
(lncRNA) (16). Collectively, results obtained with PDS,
TASQ and others such as the pyridodicarboxamide (PDC)
360A derivatives (17) (e.g. the fluorescent dye PDC-M-TO,
(18) photo-cross-linking PDC-XL (19) and affinity-tagged
PDC-biotin (20)) strongly advocate for the strategic rele-
vance of multifunctional G4-ligands, which precisely illus-
trate the critical importance of G4s in cell biology.
Here, we continued our efforts to developmultifunctional
TASQ ligands. We designed a new BioTASQ prototype (re-
ferred to as BioTASQ v.2) and performed in-depth study of
both BioTASQ probes (v.1 and v.2) as G4-specific affinity
reagents. We showed that both BioTASQs allow for captur-
ing G4s in vitro and from human cells extracts, confirming
the reliability and versatility of theG4RP protocol.We eval-
uated their efficiency via two different pull-down protocols,
highlighting the need to exercise caution in selecting biotin
linkages, whose nature (length and flexibility of the linker)
could drastically influence the nucleic acid-interacting prop-
erties of the resulting conjugates. Globally, we provide here
new insights into the mechanistic basis for the efficiency of
biotinylated TASQs as G4-specific baits for the isolation
and identification of G4-RNAs in human transcriptome,
expand the portfolio of molecular devices to study G4s in
vivo and further improve our understandings of the G4ome.
MATERIALS AND METHODS
Two-step pull-down protocol
The in vitro quadruplex capture experiments were
performed in 250 l final volume as follows: Bio-
TASQ (0, 20 and 50 M) was mixed with 5′-
fluorescently labeled Myc oligonucleotide (F-Myc, FAM-
d[5
′
GAG3TG4AG3TG4A2G3
′
]) (1 M) in Caco.K buffer,
comprised of 10 mM lithium cacodylate buffer (pH 7.2)
plus 10 mMKCl/90 mMLiCl for 2 h at 25◦C. The mixtures
were thus taken up for the first fluorescence analysis (that is,
control experiments without beads, which will be used for
normalization, see below), being distributed in 3 wells (80
l each) of a 96-well plate, using a ClarioStar® machine
(BMG Labtech) equipped with FAM filters (ex = 492 nm;
em = 516 nm). The streptavidin MagneSphere® beads
(Promega) were washed three times with Caco.K buffer:
200 l of the commercial solution of beads (1 mg.ml−1)
were washed three times with 200 l of Caco.K. After the
original solutions being reconstituted (as 250-l mixtures),
25 l (corresponding to 10% of the final volume, 25 g) of
MagneSphere® beads were added to the BioTASQ/F-Myc
mixtures; after 1-h incubation at 25◦C, beads were immo-
bilized (attracted by a magnet) (21) and the supernatant
was taken up for the second fluorescence analysis (that is,
experiments with beads), after being distributed in three
wells (80 l each) of a 96-well plate. Data analysis: raw
FAM emission (FE) values were collected as triplicates,
averaged (with SD) and treated as followed: (a) to evaluate
the impact of the beads, results obtained with solutions
of F-Myc alone and (F-Myc+beads) were compared and
showed as normalized FAM emission (NFE) values, using
NFE = [FE/FEF-Myc] × 100 (by definition, NFEF-Myc
= 100%); (b) to evaluate the BioTASQ efficiency, (F-
Myc+BioTASQ) and (F-Myc+BioTASQ+beads) were
compared (at both 20 and 50 M BioTASQ, with both
BioTASQ v.1 and v.2) and showed as NFE values, us-
ing NFE = [FE/FE(F-Myc+BioTASQ)]x100 (by definition,
NFE(F-Myc+BioTASQ) = 100%, for both BioTASQs, at both
concentrations). Next, the solid residue was resuspended
in 240 l of TBS 1X buffer, heated for 8 min at 90◦C
(under gentle stirring 800 rpm), centrifuged for 2 min
(8 900 rpm) and the supernatant was taken up for the
third fluorescent analysis (i.e. after elution from the beads),
after being distributed in three wells (80 l each) of a
96-well plate. Data analysis: raw FE values were collected
as triplicates, averaged (with SD) and treated as followed:
results obtained with solutions of (F-Myc+beads) and
(F-Myc+beads+BioTASQ) were compared (at both 20 and
50 M BioTASQ, with both BioTASQ v.1 and v.2) and
showed as NFE values, using NFE = [FE/FE(F-Myc+beads)]
(by definition, NFE(F-Myc+beads) = 1).
One-step pull-down protocol
The streptavidin MagneSphere® beads (Promega) were
washed three times with Caco.K buffer as indicated above.
BioTASQ (20 M) was mixed with various 5′-labeled
oligonucleotides (F-ON, 1 M, here: F-Myc, F-SRC,
F-22AG, F-duplex, F-TERRA, F-TRF2 and F-NRAS)
and MagneSphere® beads (25 g) in Caco.K buffer
(250 l final volume) and stirred for 16 h at 25◦C. The
beads were immobilized (attracted by a magnet) and the
supernatant was removed (21). The solid residue was
resuspended in 240 l of TBS 1X buffer, heated for 8
min at 90◦C (under gentle stirring 800 rpm) and then
centrifuged for 2 min (8 900 rpm). The supernatant was
taken up for analysis (the beads being immobilized by a
magnet), after being distributed in 3 wells (80 l each)
of a 96-well plate, using a ClarioStar® machine (BMG
Labtech) equipped with FAM filters (ex = 492 nm; em =
516 nm). Data were analyzed as above: raw FE values were
collected as triplicates, averaged (with SD) and treated as
followed: results obtained with solutions of (F-ON+beads)
and (F-ON+beads+BioTASQ) were compared (with both
BioTASQ v.1 and v.2) and showed as NFE values, using
NFE = [FE/FE(F-ON+beads)] (by definition, NFE(F-ON+beads)
= 1; for sake of clarity, NFE(F-ON+beads) is not shown in
Figure 4A). For competitive pull-down experiments: re-
sults obtained with solutions of (F-ON+beads+BioTASQ)
and (F-ON+beads+BioTASQ+competitor) were com-
pared (with ds17, ds26 and CT-DNA, with both Bio-
TASQ v.1 and v.2) and showed as NFE values, using
NFE = [FE/FE(F-ON+beads+BioTASQ)]x100 (by definition,
NFE(F-ON+beads+BioTASQ) = 100%, for both F-SRC and
F-NRAS, with both BioTASQs).
G4RP-RT-qPCR protocol
MCF7 cells were seeded at 3.5 × 105 cells per 10-cm dish
before treatment with either vehicle (PBS) or BRACO-19
5 g/ml (LD15) for 72 h. Cells were then crosslinked using
1% formaldehyde/PBS for 5 min at 25◦C and the crosslink
was then quenched with 0.125 M glycine for 5 min. Cells
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were scraped and resuspended in G4RP buffer (150 mM
KCl, 25 mM Tris pH7.4, 5 mM EDTA, 0.5 mMDTT, 0.5%
NP40, RNase inhibitor (Roche), homebrew protease in-
hibitor cocktail). Cells were then sonicated using Covaris
m220 Ultrasonicator using default settings at 10% duty for
2 min. The sonicated fractions were then incubated with
100 M BioTASQ v.1 or BioTASQ v.2 (or 100 M bi-
otin for controls) overnight at 4◦C. 5% of the sonicate was
collected as input control. 10 g of MagneSphere® beads
(Promega) were added and the extract was incubated for
2 h at 4◦C. Magnetic beads were then washed four times
in G4RP buffer for 5 min. The beads were then incubated
at 70◦C for 1 h to release captured G4-forming targets from
the beads as unfolded sequences (through the reversal of the
formaldehyde crosslink) for RT-qPCR quantification pur-
poses. TRIZOL was then used to extract the RNA from the
beads using manufacturer’s instructions.
The primer sets used for RT-qPCR are:
mRNA Forward Reverse
VEGFA 5’CCTTGCCTTGCTGC
TCTACC3’
5’AGATGTCCACCA
GGGTCTCG3’
NRAS 5’ATGACTGAGTAC
AAACTGGTGGT3’
5’CATGTATTGGTCTC
TCATGGCAC3’
HPRT1 5’ACCAGTCAACAG
GGGACATAA3’
5’CTTCGTGGGGTC
CTTTTCACC3’
MALAT1 5’AAAGCAAGGTCT
CCCCACAAG3’
5’GGTCTGTGCTAG
ATCAAAAGGCA3’
XIST 5’GGTCTGTGCTAG
ATCAAAAGGCA3’
5’AGCTCCTCGGAC
AGCTGTAA3’
RPPH1 5’GAGCTGAGTGCG
TCCTGTC3’
5’TCAGGGAGAGCC
CTGTTAGG3’
Extracted RNAwas reverse transcribed with Superscript
III (Thermos) and random hexamer primers were used ac-
cording to the manufacturer’s protocol to generate cDNA.
cDNAs were quantified for target RNAs using 2× SYBR
green mix (Bimake) and specific primer sets with three tech-
nical replicates in each assay. C(t) values of pull-down sam-
ples were normalized to the input control. Three biological
replicates were used for all RT-qPCR-based quantifications.
Exon-spanning primers for quantifying mRNA levels were
derived from Primerbank (see the Supplementary data).
RESULTS
The design of two different BioTASQs
The BioTASQ derivatives belong to the family of
biomimetic G4-ligands that uniquely interact with
G4s through a biomimetic, like-likes-like recognition
between the synthetic G-quartet of the ligand and the
native G-quartet of the G4 targets (Figure 1A) (11,12,22).
The different prototypes of TASQ studied so far display
high affinity for both DNA/RNA G4s and more im-
portantly an excellent selectivity over other nucleic acid
structures, making them well-suited to cell-based investiga-
tions (13,14,23). We recently studied a biotinylated TASQ
named BioTASQ (referred to as BioTASQ v.1 here) that
allows for purifying (pull-down protocol) and identifying
(G4RP-seq technology) transcriptomic G4-RNA targets
from human cells (15). We wondered whether our initial
molecular design was optimal, particularly regarding the
position of the biotin tag as compared to the template
of TASQ, which allows for the intramolecular G-quartet
formation. With BioTASQ v.1, we initially selected a
short, 7-membered linker (Figure 1B, Supplementary
Figures S1, S2), with the hope that it is long enough not
to affect or impede TASQ/G4 association, notably upon
streptavidin interaction. First in vitro pull-down results
showed that BioTASQ v.1 was an efficient affinity reagent,
with possible room for improvement. We thus decided
to synthesize a novel prototype that exhibits a longer,
23-membered linker (BioTASQ v.2, Figure 1B), with the
hope of discarding the possible steric clash that may occur
upon streptavidin interaction, which may be responsible for
TASQ/G4 dissociation and target release (Supplementary
Figure S2). As detailed in the Supporting Information,
the synthesis of BioTASQ v.2 was directly inspired by the
methodology developed for BioTASQ v.1, which relied
on a C-functionalized DOTA derivative we previously
described (24), making this chemical access fast and fairly
efficient (Supplementary Figures S3–S9).
The first, two-step BioTASQ-based G4-affinity pull-down
protocol
To assess whether BioTASQ v.1 and v.2 efficiently pull-
down quadruplexes from solutions in vitro, we employed
fluorescein (FAMorF)-labeled nucleic acids given that fluo-
rescence measurements allow for convenient analyses and a
high detection sensitivity. The first pull-down protocol was
attempted according to published literature (9), which al-
lows for quantifying the capture efficiency by the depletion
of FAM fluorescence from the solution (Figure 2). We first
used F-Myc (FAM-d[5
′
GAG3TG4AG3TG4A2G3
′
]), a well-
known G4-forming sequence found in the promoter region
of the Myc gene (25). F-Myc (1 M) was incubated with
increasing amounts of BioTASQ (0, 20 and 50 M) for
2h at 25◦C. The fluorescence of these solutions was mea-
sured (ex = 492 nm, em = 516 nm) to be used as con-
trols (vide infra). Then, the streptavidin-coated magnetic
beads (25 g, 10% of the final volume) were added and in-
cubated for 1 h at 25◦C. The beads were precipitated, the
supernatant collected and subjected to a second fluores-
cence analysis (Figure 2B): this allowed for quantification
of the nucleic acid capture in a differential manner, that
is, by comparison with the fluorescence before (controls,
fixed at 100%) and after addition of and incubation with
the beads (the pull-down experiment per se, whose fluores-
cence emission is expressed (in %) relative to ad hoc con-
trols). It is worth noting that these results have value inso-
far as they are compared and normalized to relevant con-
trols, the normalization being performed here in pairs, one
for each concentration (0, 20 and 50 M) and each Bio-
TASQ (v.1 and v.2), obtained in strictly identical experi-
mental conditions (see Materials and Methods). We next
quantified the amount of F-Myc immobilized on the beads:
to this end, the beads were re-suspended in TBS 1X buffer
and the bead/BioTASQ/nucleic acids assemblies dissoci-
ated by thermal treatment (8 min at 90◦C). After separa-
tion from the beads, the fluorescence of the resulting solu-
tion was measured to quantify the nucleic acid capture in a
direct manner (Figure 2C). Data were compared to control
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Figure 1. (A) Schematic representation of a guanine-rich RNA sequence (guanines as grey squares) under its random-coil (left) and folded, that is, quadru-
plex structures (G4, right). Detailed structures of guanine (left) and G-quartet (right). (B) Structure of both BioTASQ v.1 and v.2 (left) displaying a biotin
affinity tag and schematic representation of its closed, G4-affinic conformation (right), in which the intramolecular G-quartet is formed.
experiments performed without BioTASQ (normalized to
1, see Materials and Methods) to take into account possi-
ble unspecific binding of F-Myc on the beads.
Our data demonstrated that both BioTASQ efficiently
capture G4-DNA from solution, in a concentration-
dependent manner. However, the overall efficiency of the
process was restricted to 46% at best (Figure 2B: 18–45%
and 42–46% decrease of the fluorescence as compared to
controls (normalized to 100%) for BioTASQ v.1 and v.2, re-
spectively), in a manner that was not dependent on the used
G4-forming oligonucleotides since comparable results were
obtained with 2 other G4s (Supplementary Figure S10),
i.e. the DNA F-SRC (FAM-d[5
′
G3AG3AG3CTG53
′
]) and
the RNA F-TERRA (FAM-r[5
′
AG3(U2AG3)33
′
]), two se-
quences found in the SRC gene (10) and telomeric tran-
scripts, (26) respectively. The efficiency of the BioTASQ
capture of G4s in solution (up to 45 and 46% for Bio-
TASQ v.1 and v.2, respectively) was not consistent with
the excess of ligand as compared to the DNA (20- to 50-
fold). This could be attributed to two potential reasons: the
non-covalent, that is, reversible TASQ/G4 association that
poorly withstands the streptavidin capture step or the dis-
ruption of the TASQ/G4 interaction by the introduction
of biotin tags. The small difference between BioTASQ v.1
and v.2 efficiencies suggests that it was not due to the afore-
mentioned target release due to streptavidin/biotin associ-
ation. The results collected after the release of F-Myc from
the beads by a short thermal denaturation step (8 min at
90◦C, Figure 2C) also provided dose-response results but
confirmed the modest efficiency of the overall process. In-
deed, as compared to controls (that is, the fluorescence of
samples without BioTASQ, normalized to 1), the fluores-
cence of BioTASQ-enriched fractions increased, but only in
a modest manner (2.2–2.8 and 3.7–5.4-fold increase of the
fluorescence as compared to controls for BioTASQ v.1 and
v.2, respectively). This again pointed to the need for opti-
mizing the pull-down protocol. In particular, we reasoned
that the biotin tag may alter the efficiency of the BioTASQs
as G4-ligands per se and decided to investigate this through
in vitro affinity assays.
Assessing the interaction between BioTASQ and G4s
The apparent affinity of each new G4-ligand is quantified
via fluorescence resonance energy transfer (FRET)-
melting experiments. (27) Both BioTASQs were thus
assayed against the dual-labeled F-Myc-T (FAM-
d[5
′
GAG3TG4AG3TG4A2G3
′
]-TAMRA), in a dose-
response manner (experiments were performed with 1
and 5 M ligand versus 0.2 M DNA, i.e. 5 and 25 mol.
equiv. ligand). Results seen in Figures 3 were surprising:
first, the quadruplex-stabilizing capacity of both Bio-
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Figure 2. (A) Schematic representation of the in vitro pull-down protocol. (B,C) Results of the two-step pull-down experiments quantified through the
fluorescence analysis of the supernatant (B) and of the precipitate after phase separation and release from the beads (C) of experiments carried out with
F-Myc (1 M), in absence (black bars) or presence of BioTASQ (20–50 M, colored bars).
Figure 3. (A) FRET-melting results obtained with F-myc-T (0.2 M, black line) and ligands (5 M), either BioTASQ v.1 (brown line), BioTASQ v.2
(orange line), PNADOTASQ (dark grey line) or biotin (grey line). (B) Summary of T1/2 values obtained with F-myc-T (0.2 M) and increasing amounts
of ligands (1 and 5 M), either BioTASQ v.1, BioTASQ v.2, PNADOTASQ or biotin; inset: a schematic representation of the possible biotin/guanine
association. (C) Schematic representation of the biotin/guanine interactions that could take place intramolecularly within the structure of BioTASQ v.1
(left panel) or BioTASQ v.2 (right panel).
TASQs was strongly decreased as compared to the parent
PNADOTASQ (11,28) (T1/2 = 2.4 and 0.4◦C for BioTASQ
v.1 and v.2, respectively versus 14.4◦C for PNADOTASQ at
1 M ligand concentration); second, the BioTASQ with
the longest biotin appendage (BioTASQ v.2) was even
less efficient than BioTASQ v.1 (with T1/2 up to 8.4 and
2.2◦C for BioTASQ v.1 and v.2, respectively). These results
clearly demonstrated that the introduction of the biotin
tag negatively impacted the quadruplex-stabilizing prop-
erties of BioTASQs, reminiscently of what was observed
with PDS, (9) in a manner that was connected with the
length and flexibility of the biotin linker (the shorter, the
better). To further investigate this, we performed control
FRET-melting experiments with biotin (Figures 3). Quite
unexpectedly, we found that biotin destabilized F-Myc-T
(with T1/2 up to –4.4◦C at 5 M ligand concentration).
The origins of this interaction remain at present unclear; we
postulate that biotin may interact with guanines through
the creation of hydrogen bonds (H-bonds, insert Figure 3B)
given that it comprises an ureido ring (fused to a tetrahy-
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drothiophene ring) that is known to target GC base-pair via
H-bond-directed G-interaction. (29) In our conditions, the
biotin/guanine association took place with quadruplexes
when the biotin was used alone (Figure 3A,B) and most
certainly occurred intramolecularly within the BioTASQ
structure (Figure 3C): this could explain why the ligand
with the longer linker (BioTASQ v.2) was less effective
in stabilizing quadruplexes than BioTASQ v.1 since the
long linker provides more flexibility and thus, makes the
intramolecular biotin/guanine association sterically easier
and more stable. We thus decided to modify the in vitro
pull-down protocol according to this new data.
The second, one-step BioTASQ-based G4-affinity pull-down
protocol
We reasoned that a way to improve the efficiency of the
pull-down protocol could be to hijack biotin from guanine
poisoning: to this end, we decided to directly co-incubate
the oligonucleotides, BioTASQ and the magnetic beads in
order to favor the streptavidin/biotin association at the
very beginning of the experiment, thus making this novel
approach a one-step protocol. To assess the validity of this
strategy, we used 3 G4-DNAs, which correspond to se-
quences found in Myc and SRC genes (F-Myc and F-SRC)
and in the human telomeric region (F-22AG, FAM-
d[5
′
AG3(T2AG3)33
′
]), (30) 3 G4-RNAs that correspond to
sequences found in the mRNA of TRF2 and NRAS genes
(F-TRF2 and F-NRAS, FAM-r[5
′
CG3AG3CG4AG3C3
′
]
and FAM-r[5
′
G3AG4CG3UCUG33
′
], respectively) (31)
and in the human telomeric transcripts (F-TERRA),
along with 1 duplex used as control (F-duplex, FAM-
d[5
′
(TA)2GC(TA)2T6(TA)2GC(TA)23
′
]). The labeled
oligonucleotides (1 M) were incubated with both Bio-
TASQ (20 M) and the streptavidin-coated magnetic
beads (25 g). After an overnight incubation at 25◦C, the
beads were precipitated, supernatant removed and beads
re-suspended in TBS 1X buffer before thermal denatu-
ration (8 min at 90◦C). After separation from the beads,
fluorescence of the solution was monitored to quantify the
nucleic acid capture.
Results seen in Figure 4A highlighted the better over-
all efficiency of the one-step strategy as compared to the
two-step protocol: the FAM fluorescence increased 26-
fold (as compared to controls, that is, the fluorescence of
samples without BioTASQ treatment, normalized to 1 as
above) with G4-DNA (versus 5.4-fold for the two-step pro-
tocol, Figure 2) and 44-fold with G4-RNA. Significant dis-
crepancies were nonetheless noticeable: first, the capture of
G4-RNA (from 10.9- to 44.1-fold) was more efficient than
that of G4-DNA (from 2.5- to 26.3-fold). This could be at-
tributed to the unique topology of the G4-RNA (parallel
or type I quadruplex), (32) which makes their external G-
quartet more accessible to BioTASQ, that is, more suited
to interact efficiently with the sterically demanding TASQ
ligand. This assumption was further substantiated by the
modest results obtained with the highly polymorphic F-
22AG (3.3- and 2.5-fold enhancement with BioTASQ v.1
and v.2, respectively), which was mainly found as a hybrid-
type (or type II) quadruplex under the condition of our as-
say. Second, the efficiency of BioTASQ v.2 (from 2.5- to
44.1-fold enhancement) was better than that of BioTASQ
v.1 (from 3.3- to 23.8-fold enhancement), which was not in
line with the FRET-melting results (with T1/2 up to 8.4
and 2.2◦C for BioTASQ v.1 and v.2, respectively, Figure 3),
therefore supporting the relevance of the biotin hijacking
strategy. Finally, none of the BioTASQ interacted with F-
duplex (0.6- and 0.7-fold enhancement, Figure 4): this indi-
cated that while the introduction of the biotin tag strongly
affects the G4-stabilizing properties of the TASQ, it does
not alter their specificity toward G4s.
This was further investigated via competitive pull-
down experiments, performed with 1 M labeled
G4s (1 G4-DNA, F-SRC and 1 G4-RNA, F-NRAS)
in the presence of an excess of unlabeled duplex
competitors, including the synthetic duplexes ds17
(d[5
′
C2AGT2C(GTA)2AC33
′
]/d[5
′
G3T(TAC)2GA2CTG23
′
],
20 M) and ds26 (the self-complementary sequence
d[5
′
CA2TCG2ATCGA2T2CGATC2GAT2G3
′
], 20 M)
or DNA extracts (calf thymus DNA, or ctDNA, 100
M). Results seen in Figure 4B demonstrated that i- both
BioTASQs can efficiently capture G4s in the presence of
duplex competitors (76–114% efficiency with G4-DNA
and 74–104% with G4-RNA as compared to control
experiments carried out without competitor), and ii- that
BioTASQ v.2 performed better in the duplex competition,
with an efficiency comprised between 97–114% with F-
SRC and 91–104% with F-NRAS (versus 76–112% with
F-SRC and 75–90% with F-NRAS for BioTASQ v.1).
Collectively, these results validated the strategic relevance
of the one-step pull-down protocol and demonstrated that
both BioTASQs are promising molecular tools to purify
G4s for cell-based investigations.
Using both BioTASQs in G4RP-RT-qPCR protocols
We then decided to implement bothBioTASQs in theG4RP
protocol that allows for both isolating/identifying RNA
quadruplexes fromhuman cells and assessing the changes in
the G4ome induced by live-cell treatment with G4-ligands.
(15) As schematically depicted in Figure 5A,MCF7 human
breast cancer cells were first cross-linked with formaldehyde
to structurally immobilize transiently folded quadruplexes;
harvested cells were then sonicated briefly to release cel-
lular content, and cell lysates were incubated with either
BioTASQ v.1 or v.2 overnight before affinity purification
with magnetic streptavidin beads. The reverse transcription
quantitative polymerase chain reaction (RT-qPCR)method
was employed to analyze BioTASQ-enriched fractions, al-
leviating the need of removing DNA from cell extracts
given that RT-qPCRquantifications were done usingRNA-
specific primers. As seen in Figures 5B,C, results collected
through the G4RP-RT-qPCR protocol showed that non-
specific binding was negligible (biotin used as control) while
demonstrating the enrichment of two firmly establishedG4-
richmRNAs, i.e. VEGFA (Vascular endothelial growth fac-
tor A) (33) and NRAS (neuroblastoma rat sarcoma viral
oncogene). (34) Of note, BioTASQ v.2 was again found to
bemore efficient than BioTASQ v.1 in theG4RP-RT-qPCR
protocol (59- and 25-fold improvement as compared to bi-
otin for VEGFA and NRAS, respectively, versus 22- and
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Figure 4. (A) One-step pull-down results (FAM intensity of F-ON after release from the beads) for experiments carried out with 1 M of G4-DNA
(F-Myc, F-SRC and F-22AG, plain bars), ds-DNA (F-duplex, cross-hatched bars) or G4-RNA (F-TERRA, F-TRF2 and F-NRAS, diagonally hatched
bars) and 20 M of both BioTASQ (v.1 and v.2, brown and orange bars, respectively). (B) Competitive pull-down experiments carried out with 1 M of
G4-DNA (F-SRC) or G4-RNA (F-NRAS), 20 M of both BioTASQ (v.1 and v.2) in absence or presence of competitive ds-DNA (either 20 M of ds17
or ds26, or 100 M of calf thymus DNA (ctDNA)).
Figure 5. (A) Schematic representation of the G4RP-RT-qPCR protocol. (B,C) G4RP signals of biotin control versus BioTASQ v.1 (B) and BioTASQ
v.2 (C) through RT-qPCR quantification of VEGFA and NRAS mRNA levels in untreated MCF7 cells. Three biological replicates were used for the
quantifications. (D,E) G4RP signals obtained with BioTASQ v.1 (D) and BioTASQ v.2 (E) quantified with RT-qPCR measurements of MALAT1, XIST,
RPPH1, VEGFA, NRAS and HPRT1 RNA levels in untreated (grey bars) or BRACO-19-treated MCF7 cells (black bars). Values are normalized to their
individual input control used for the BioTASQ pull-down. Two-way ANOVA was performed against No Rx control. *P < 0.05, **P < .01, ***P < 0.001.
Experiments were conducted with three biological replicates. Error bars represent standard error of the mean (SEM).
16-fold for BioTASQ v.1), in line with its overall better per-
formances in in vitro pull-down assays.
Next, we focused on MCF7 cells treated with BRACO-
19. (35) We previously demonstrated that treatment with
G4-ligands significantly increased G4RP signals of G4-
harboring RNAs, (15) most notably of long non-coding
RNA (lncRNA) (16,36) such as MALAT1 (metastasis as-
sociated lung adenocarcinoma transcript 1), (37) XIST
(X-inactive specific transcript) (38) and RPPH1 (ribonu-
clease P RNA component H1). (39) We thus evaluated
here the BRACO-19-induced modifications of G4RP sig-
nals using the two BioTASQs. As seen in Figures 5D,E,
both BioTASQs can specifically enrich for G4-containing
RNA sequences including lncRNA (MALAT1, XIST and
RPPH1), mRNA (VEGFA and NRAS), while no changes
was observed for HPRT1 (hypoxanthine phosphoribosyl-
transferase 1), a housekeeping gene transcript that was se-
lected as an unstructured RNA control. Trends were sim-
ilar in both conditions, given that i- the enrichments ob-
tained with both BioTASQs were higher for transcripts
from BRACO-19-treated cells (black bars) than for un-
treated cells (gray bars), with the notable exception of the
control HPRT1 (control); and ii- the order of efficiencies
for lncRNA is MALAT1 > XIST > RPPH1 (with 18.6,
10.1 and 4.4% of input RNA for BioTASQ v.1, and 10.1,7.8
and 4.5% for BioTASQ v.2), and for protein coding RNA
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is VEGFA > NRAS (with 11.8 and 11.1 for BioTASQ v.1,
and 12.8 and 11.6% for BioTASQ v.2). Some discrepancies
between the two BioTASQs were nonetheless noted: first,
the lower overall enrichment of BioTASQ v.1 in untreated
cells (up to 3.5% of input RNA) as compared to BioTASQ
v.2 (up to 5.5%), which could originate in a better acces-
sibility of the biotin bait once BioTASQ v.2 is embedded
in the RNA/protein (RNP) complexes; second, the more
sensitive BRACO-19-induced changes with BioTASQ v.1
(up to 9.5-fold enrichment as compared to untreated cells)
than with BioTASQ v.2 (up to 4.3-fold enrichment), since
G4 ligand-treatments may result in G4 targets being more
accessible (thus decreasing the BioTASQ v.1 versus v.2 dif-
ferences, with the notable exception of MALAT1 here). Al-
together, these results highlight that the choice of a suit-
able BioTASQmolecule for performing G4RP experiments
must be done according to the purpose of the experiments,
that is, using BioTASQ v.2 for assessing the prevalence of
less accessible G4s in cells, and BioTASQ v.1 for evaluating
theG4-ligand induced changes in the human transcriptome.
They also confirm that both BioTASQs are efficient devices
for the isolation and identification of G4-containing RNAs
from human cells as well as for gaining precious insights
into the G4ome in vivo.
DISCUSSION
The ability of G-rich DNA/RNA sequences to adopt G4
secondary structures in vitro has been thoroughly docu-
mented over the past decades through a wide range of bio-
physical and biochemical techniques (40). To do so in liv-
ing cells represents a bigger challenge, owing to the many–
and yet poorly understood–cellular mechanisms the cell
evolved to resolve G4 structures efficiently (41). Small-
molecular probes uniquely offer the possibility of interact-
ing with and isolating G4 nucleic acid targets from func-
tional cells and identifying these purified targets via next-
generation sequencing technologies (1,7,42). Here, we re-
port on two biotinylated biomimetic quadruplex probes
(BioTASQ v.1 and v.2) and their use as affinity reagents
to purify quadruplexes in vitro and in vivo through G4-
selective precipitation approaches. The efficiency of these
new molecular probes was studied through their interac-
tions with different G4-forming sequences (both biologi-
cally relevantDNA (Myc, SRC, 22AG) andRNAsequences
(TRF2, NRAS, TERRA)), and different pull-down pro-
tocols (one- and two-step protocols, in both comparative
and competitive manners), optimized to the specifications
of biotinylated G4-ligands (in response to the unexpected
guanine-interacting properties of the biotin). The demon-
stration that both BioTASQs are efficient to assess the
prevalence of G4-RNA in the human transcriptome (focus-
ing on both coding (VEGFA and NRAS) and non-coding
RNAs (MALAT1, XIST andRPPH1)) and that the quanti-
tative changes in their abundance in response to treatments
withG4-ligands (here, BRACO-19) can be easily monitored
via the G4RP-RT-qPCR technology lends further credence
to the use of biotinylated TASQ as highly specific molec-
ular bait for quadruplexes. We anticipate the use of these
new-generation molecular tools will contribute to the con-
tinued identification of cellular DNA/RNA quadruplexes
as key regulators of gene expression in normal and disease-
associated changes in cell biology and as promising tar-
gets for innovative treatments of genetic dysregulations and
associated diseases, i.e. cancers and neurodegenerative dis-
eases.
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